Cargando…

Evaluation of Sarcopenia, Frailty, and Inflammation on Adverse Events and Survival Outcomes in Patients with Oral Cavity Squamous Cell Carcinoma under Adjuvant Chemoradiotherapy

In this study, we aimed to evaluate the prognostic impact of sarcopenia, five-item modified frailty index (mFI-5), neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) in patients with oral cavity squamous cell carcinoma (OSCC) treated with adjuvant chemoradiotherapy (CRT) and thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chun-Hou, Chen, Peir-Rorg, Lue, Kun-Han, Hsieh, Tsung-Cheng, Chou, Yu-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464994/ https://www.ncbi.nlm.nih.gov/pubmed/34575713 http://dx.doi.org/10.3390/jpm11090936

Ejemplares similares

Association between Sarcopenia and Immediate Complications and Mortality in Patients with Oral Cavity Squamous Cell Carcinoma Undergoing Surgery
por: Huang, Chun-Hou, et al.
Publicado: (2022)

Association of Neutrophil-to-Lymphocyte Ratio and Bloodstream Infections with Survival after Curative-Intent Treatment in Elderly Patients with Oral Cavity Squamous Cell Carcinoma
por: Huang, Chun-Hou, et al.
Publicado: (2023)

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
por: Yap, Wing-Keen, et al.
Publicado: (2022)

Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension
por: Huang, Pei-Wei, et al.
Publicado: (2022)

Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy
por: Qian, Junchao, et al.
Publicado: (2022)

Optimal Frailty Dimensions for Assessing Frailty and Predicting Chemotherapy Adverse Events in Older Taiwanese Cancer Patients
por: Ho, Ya-Wen, et al.
Publicado: (2022)

Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy
por: Lin, Yu-Ching, et al.
Publicado: (2021)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The Role of Sirtuins in Sarcopenia and Frailty
por: Anwar, Masroor, et al.
Publicado: (2023)

Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer
por: Lin, Yu-Ching, et al.
Publicado: (2021)

Diabetes related fatigue sarcopenia, frailty
por: Lien, Angela Shin‐Yu, et al.
Publicado: (2017)

Sarcopenia, Frailty, and Diabetes in Older Adults
por: Jang, Hak Chul
Publicado: (2016)

The frailty phenotype and sarcopenia: Similar but not the same
por: Cesari, Matteo
Publicado: (2019)

Mitochondria: between aging, frailty and sarcopenia
por: Davin, Annalisa, et al.
Publicado: (2023)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Xu, Ying-Ying, et al.
Publicado: (2021)

Frailty, gaps in care coordination, and preventable adverse events
por: Akinyelure, Oluwasegun P., et al.
Publicado: (2022)

Automated Electronic Frailty Index–Identified Frailty Status and Associated Postsurgical Adverse Events
por: Khanna, Ashish K., et al.
Publicado: (2023)

Prognostic significance of the preoperative systemic immune‐inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy
por: Hung, Sheng‐Ping, et al.
Publicado: (2020)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
por: Cesari, Matteo, et al.
Publicado: (2022)

Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Bahat, Zumrut, et al.
Publicado: (2022)

Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
por: Greco, Emanuela A., et al.
Publicado: (2019)

Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice
por: Wong, Limy, et al.
Publicado: (2021)

Frailty and Sarcopenia in Acute‐on‐Chronic Liver Failure
por: Puchades Renau, Lorena, et al.
Publicado: (2021)

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
por: Iacob, Speranta, et al.
Publicado: (2022)

Healthcare cost expenditures associated to frailty and sarcopenia
por: Álvarez-Bustos, Alejandro, et al.
Publicado: (2022)

Innovation in Digital Health Interventions for Frailty and Sarcopenia
por: Kato, Yuki, et al.
Publicado: (2023)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
por: Chen, Mingqiu, et al.
Publicado: (2018)

Comparison of surgical complications after curative surgery in patients with oral cavity squamous cell carcinoma and sarcopenia
por: Zeng, Shuang, et al.
Publicado: (2022)

Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
por: Tamura, Yoshiaki, et al.
Publicado: (2018)

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors
por: Khan, Qamar J., et al.
Publicado: (2010)

Frailty Is Predictive of Adverse Postoperative Events in Patients Undergoing Lumbar Fusion
por: Leven, Dante M., et al.
Publicado: (2017)

Association Between Sarcopenia and Adverse Events Following Transcatheter Aortic Valve Implantation
por: Brown, Andrew D., et al.
Publicado: (2021)

From sarcopenia to frailty: a road less traveled
por: Morley, John E., et al.
Publicado: (2014)

Sarcopenia and Physical Frailty: Two Sides of the Same Coin
por: Cesari, Matteo, et al.
Publicado: (2014)

Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty
por: Uto, Nanami Sameshima, et al.
Publicado: (2018)

Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?
por: Picca, Anna, et al.
Publicado: (2020)

Management of Dynapenia, Sarcopenia, and Frailty: The Role of Physical Exercise
por: Sampaio, Ricardo Aurélio Carvalho, et al.
Publicado: (2020)

Frailty and Sarcopenia in Older Patients Receiving Kidney Transplantation
por: Gandolfini, Ilaria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iik0gb4l20fo326b2bafd76u0h